Who Paid My Doc Search
Menu
Research study Program year 2022 Source: CMS Open Payments

Phase 3b Open-Label, Multicenter, Safety Study of BIIB037 (aducanumab) in Subjects with Alzheimer's disease Who Had Previously Participated in the Aducanumab Studies221AD103, 221AD301, 221AD302 and 221AD205

Research payments

$23,159,778

105 payments

Through program year 2022, $23,159,778 in research payments was reported against Phase 3b Open-Label, Multicenter, Safety Study of BIIB037 (aducanumab) in Subjects with Alzheimer's disease Who Had Previously Participated in the Aducanumab Studies221AD103, 221AD301, 221AD302 and 221AD205, across 105 payments, paid by Biogen, Inc..

Paid by
Biogen, Inc.
ClinicalTrials.gov
No trial number was reported for this study

By program year

1 row
Year Kind Amount Payments
2022 Research $23,159,778 105

Breakdown

Who paid Research payments · program year 2022
  1. Biogen, Inc. $23,159,778 105 payments
Who received the money Research payments · program year 2022
  1. Erg Holding Company LLC Organisation paid for research $2,045,899 3 payments
  2. Yale University Health Plan Organisation paid for research $1,052,236 2 payments
  3. Advanced Memory Research Institute Of Nj Pc Organisation paid for research $999,739 1 payment
  4. Butler Hospital Teaching hospital · RI $920,126 2 payments
  5. Kingfisher Cooperative LLC Organisation paid for research $852,294 1 payment
  6. Bioclinica Research Organisation paid for research $768,229 2 payments
  7. Neurology Clinic Pc Organisation paid for research $763,041 1 payment
  8. Cleveland Clinic Hospital Teaching hospital · OH $635,285 2 payments
  9. Alexian Brothers Health System Organisation paid for research $619,055 1 payment
  10. Clinical Trial Network LLC Organisation paid for research $547,533 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record